BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 32999425)

  • 1. Response to "the role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection".
    Rappaport SM
    J Expo Sci Environ Epidemiol; 2020 Nov; 30(6):905. PubMed ID: 32999425
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.
    Naughton SX; Raval U; Harary JM; Pasinetti GM
    J Expo Sci Environ Epidemiol; 2020 Sep; 30(5):776-777. PubMed ID: 32398780
    [No Abstract]   [Full Text] [Related]  

  • 3. Host genetic factors and susceptibility to SARS-CoV-2 infection.
    Schurr TG
    Am J Hum Biol; 2020 Sep; 32(5):e23497. PubMed ID: 32876373
    [No Abstract]   [Full Text] [Related]  

  • 4. RESILIENCE AND COVID-19.
    Solano Gámez A
    Rev Colomb Obstet Ginecol; 2020 Mar; 71(1):7-8. PubMed ID: 32418371
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
    McAlinden KD; Eapen MS; Lu W; Chia C; Haug G; Sohal SS
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis".
    Forster P; Forster L
    JMIR Public Health Surveill; 2020 Nov; 6(4):e23542. PubMed ID: 33174859
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Vulnerability and resilience demonstrated: Cardiac surgeons during coronavirus disease 2019 (COVID-19).
    Silvestry SC
    J Thorac Cardiovasc Surg; 2020 Oct; 160(4):949-950. PubMed ID: 32651004
    [No Abstract]   [Full Text] [Related]  

  • 8. Math and aftermath of COVID-19 pandemic and its interrelationship from the resilience perspective.
    Ćurković M; Košec A; Ćurković D
    J Infect; 2020 Aug; 81(2):e173-e174. PubMed ID: 32544412
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical Imaging Findings in Leukemia With SARS-CoV-2 Infection.
    Zhou S; Wu G
    AJR Am J Roentgenol; 2020 Aug; 215(2):W31-W32. PubMed ID: 32352310
    [No Abstract]   [Full Text] [Related]  

  • 10. Exposome and Immunity Training: How Pathogen Exposure Order Influences Innate Immune Cell Lineage Commitment and Function.
    Adams K; Weber KS; Johnson SM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dilemmas of the classification of SARS-CoV-2 infection without clinical manifestations: Asymptomatic or presymptomatic.
    Arteaga-Livias K; Pecho-Silva S; Panduro-Correa V; Rodríguez-Morales AJ
    J Formos Med Assoc; 2020 Jul; 119(7):1237-1238. PubMed ID: 32405157
    [No Abstract]   [Full Text] [Related]  

  • 12. Resilience or resistance: A personal response to COVID-19.
    Cleland J
    Med Educ; 2020 Jul; 54(7):589-590. PubMed ID: 32248564
    [No Abstract]   [Full Text] [Related]  

  • 13. Asymptomatic SARS-CoV-2 infection.
    Ooi EE; Low JG
    Lancet Infect Dis; 2020 Sep; 20(9):996-998. PubMed ID: 32539989
    [No Abstract]   [Full Text] [Related]  

  • 14. A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).
    Awais S; Shah SFH; Shah SGS
    Int J Surg; 2020 Nov; 83():28-29. PubMed ID: 32927142
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection.
    Frija-Masson J; Debray MP; Gilbert M; Lescure FX; Travert F; Borie R; Khalil A; Crestani B; d'Ortho MP; Bancal C
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32554533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does active smoking worsen Covid-19?
    Carmona-Bayonas A; Jimenez-Fonseca P; Sánchez Arraez Á; Álvarez Manceñido F; Castañón E
    Eur J Intern Med; 2020 Jul; 77():129-131. PubMed ID: 32507518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.
    Ahlén G; Frelin L; Nikouyan N; Weber F; Höglund U; Larsson O; Westman M; Tuvesson O; Gidlund EK; Cadossi M; Appelberg S; Mirazimi A; Sällberg M;
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661140
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.
    Hu YY; Ji DP; Yu YY; Li YJ; Li B; Hou GH; Zhang XD; Duan CC; Hu RB; Xu J
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1885-1888. PubMed ID: 33108863
    [No Abstract]   [Full Text] [Related]  

  • 19. Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect.
    Drak Alsibai K; Michaud C; Taquet A; Demar M; Blaizot R
    Pathology; 2020 Dec; 52(7):816-818. PubMed ID: 32863022
    [No Abstract]   [Full Text] [Related]  

  • 20. Back to normal? Building community resilience after COVID-19.
    Penkler M; Müller R; Kenney M; Hanson M
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):664-665. PubMed ID: 32707106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.